152 related articles for article (PubMed ID: 12376547)
1. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation.
He Y; Szapary D; Simons SS
J Biol Chem; 2002 Dec; 277(51):49256-66. PubMed ID: 12376547
[TBL] [Abstract][Full Text] [Related]
2. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
3. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
Szapary D; Huang Y; Simons SS
Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
5. Structure/activity elements of the multifunctional protein, GMEB-1. Characterization of domains relevant for the modulation of glucocorticoid receptor transactivation properties.
Chen J; Kaul S; Simons SS
J Biol Chem; 2002 Jun; 277(24):22053-62. PubMed ID: 11934901
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription.
Chen S; Sarlis NJ; Simons SS
J Biol Chem; 2000 Sep; 275(39):30106-17. PubMed ID: 10899170
[TBL] [Abstract][Full Text] [Related]
7. Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations.
Khan SH; Awasthi S; Guo C; Goswami D; Ling J; Griffin PR; Simons SS; Kumar R
J Biol Chem; 2012 Dec; 287(53):44546-60. PubMed ID: 23132854
[TBL] [Abstract][Full Text] [Related]
8. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
Cho S; Blackford JA; Simons SS
Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
[TBL] [Abstract][Full Text] [Related]
9. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
Wang D; Simons SS
Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
[TBL] [Abstract][Full Text] [Related]
10. Modulation of transcription parameters in glucocorticoid receptor-mediated repression.
Sun Y; Tao YG; Kagan BL; He Y; Simons SS
Mol Cell Endocrinol; 2008 Nov; 295(1-2):59-69. PubMed ID: 18583028
[TBL] [Abstract][Full Text] [Related]
11. Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.
Wang D; Wang Q; Awasthi S; Simons SS
Biochemistry; 2007 Jul; 46(27):8036-49. PubMed ID: 17571860
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
[TBL] [Abstract][Full Text] [Related]
13. PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation.
Zhang Z; Sun Y; Cho YW; Chow CC; Simons SS
J Biol Chem; 2013 Jan; 288(1):42-58. PubMed ID: 23161582
[TBL] [Abstract][Full Text] [Related]
14. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
15. Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors.
Wang Q; Anzick S; Richter WF; Meltzer P; Simons SS
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):197-210. PubMed ID: 15336697
[TBL] [Abstract][Full Text] [Related]
16. Nuclear structure-associated TIF2 recruits glucocorticoid receptor and its target DNA.
Ogawa H; Yu RT; Haraguchi T; Hiraoka Y; Nakatani Y; Morohashi K; Umesono K
Biochem Biophys Res Commun; 2004 Jul; 320(1):218-25. PubMed ID: 15207724
[TBL] [Abstract][Full Text] [Related]
17. Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.
Awasthi S; Simons SS
Mol Cell Endocrinol; 2012 May; 355(1):121-34. PubMed ID: 22342989
[TBL] [Abstract][Full Text] [Related]
18. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.
Voegel JJ; Heine MJ; Tini M; Vivat V; Chambon P; Gronemeyer H
EMBO J; 1998 Jan; 17(2):507-19. PubMed ID: 9430642
[TBL] [Abstract][Full Text] [Related]
19. A second pathway for modulating glucocorticoid receptor transactivation properties.
Chen S; Simons SS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):129-42. PubMed ID: 12581885
[TBL] [Abstract][Full Text] [Related]
20. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]